A comprehensive guidelines-based approach reduces cardiovascular risk in everyday practice: the VARO study

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10364026" target="_blank" >RIV/00216208:11110/17:10364026 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00023001:_____/17:00076046 RIV/00064165:_____/17:10364026

Výsledek na webu

<a href="http://dx.doi.org/10.5114/aoms.2016.64865" target="_blank" >http://dx.doi.org/10.5114/aoms.2016.64865</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5114/aoms.2016.64865" target="_blank" >10.5114/aoms.2016.64865</a>

Jazyk výsledku

angličtina

Název v původním jazyce

A comprehensive guidelines-based approach reduces cardiovascular risk in everyday practice: the VARO study

Popis výsledku v původním jazyce

Introduction: The aim of study was to investigate the possibility of cardiovascular risk improvement through systematic identification of high-risk individuals and treatment in accordance with current guidelines using modern therapy in daily clinical practice. Material and methods: Two hundred and sixty-three physicians participated in the study. The physicians were asked to screen for cardiovascular risk factors in patients presenting with unrelated problems and to re-evaluate the attainment of treatment goals in those with already known risk factors. Each physician enrolled up to 20 consecutive patients with hypertension and/or hyperlipidemia. A total of 3015 patients were included. Cardiovascular risk was assessed using the SCORE system. Risk factors were treated in accordance with current national guidelines. The therapy of hyperlipidemia and hypertension was preferentially based on rosuvastatin, amlodipine and valsartan. Further medication was at the discretion of the attending physician. Patients were examined at baseline and after 3 and 6 months.

Název v anglickém jazyce

A comprehensive guidelines-based approach reduces cardiovascular risk in everyday practice: the VARO study

Popis výsledku anglicky

Introduction: The aim of study was to investigate the possibility of cardiovascular risk improvement through systematic identification of high-risk individuals and treatment in accordance with current guidelines using modern therapy in daily clinical practice. Material and methods: Two hundred and sixty-three physicians participated in the study. The physicians were asked to screen for cardiovascular risk factors in patients presenting with unrelated problems and to re-evaluate the attainment of treatment goals in those with already known risk factors. Each physician enrolled up to 20 consecutive patients with hypertension and/or hyperlipidemia. A total of 3015 patients were included. Cardiovascular risk was assessed using the SCORE system. Risk factors were treated in accordance with current national guidelines. The therapy of hyperlipidemia and hypertension was preferentially based on rosuvastatin, amlodipine and valsartan. Further medication was at the discretion of the attending physician. Patients were examined at baseline and after 3 and 6 months.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Archives of Medical Science

ISSN

1734-1922

e-ISSN

—

Svazek periodika

13

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

PL - Polská republika

Počet stran výsledku

6

Strana od-do

705-710

Kód UT WoS článku

000407268100001

EID výsledku v databázi Scopus

2-s2.0-85020880437